 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 1999, 19(24):10680-10693
A Kv1.5 to Kv1.3 Switch in Endogenous Hippocampal Microglia and a
Role in Proliferation
Suhas A.
Kotecha and
Lyanne C.
Schlichter
Department of Physiology, University of Toronto, Toronto, Ontario,
Canada M5S 1A1, and Toronto Western Research Institute,
University Health Network, Toronto, Ontario, Canada M5T 2S8
 |
ABSTRACT |
The proliferation of microglia is a normal process in CNS
development and in the defense against pathological insults, although, paradoxically, it contributes to several brain diseases. We have examined the types of voltage-activated K+ currents
(Kv) and their roles in microglial proliferation. Microglia were
tissue-printed directly from the hippocampal region using brain slices
from 5- to 14-d-old rats. Immediately after tissue prints were
prepared, unipolar and bipolar microglia expressed a large Kv current,
and the cells were not proliferating. Surprisingly, this current was
biophysically and pharmacologically distinct from Kv1.3, which has been
found in dissociated, cultured microglia, but it was very similar to
Kv1.5. After several days in culture the microglia became highly
proliferative, and although the Kv prevalence and current density
decreased, many cells exhibited a prominent Kv that was
indistinguishable from Kv1.3. The Kv1.5-like current was present in
nonproliferating cells, whereas proliferating cells expressed the
Kv1.3-like current. Immunocytochemical staining showed a dramatic shift
in expression and localization of Kv1.3 and Kv1.5 proteins in
microglia: Kv1.5 moving away from the surface and Kv1.3 moving to the
surface as the cells were cultured. K+ channel
blockers inhibited proliferation, and the pharmacology of this
inhibition correlated with the type of Kv current expressed. Our study,
which introduces a method for the physiological examination of
microglia from identified brain regions, demonstrates the differential expression of two functional Kv subunits and shows that a functional delayed rectifier current is necessary for microglia proliferation.
Key words:
tissue printing; brain slice; Kv channels; neuroimmune
cells; glial cells; cell proliferation; channel expression; channel
localization
 |
INTRODUCTION |
Microglia are macrophage-like cells
of the CNS. They are normally beneficial, producing growth factors,
protecting the CNS against pathogens, and phagocytosing cellular debris
from neurons and glia that are removed during development. However,
because microglia rapidly activate after CNS injury and can be
surprisingly damaging, it is important to selectively control their
detrimental functions (for review, see Gehrmann et al., 1995 ; Streit
and Kincaid-Colton, 1995 ; Kreutzberg, 1996 ; Perry and Gordon,
1997 ). Microglia are distributed throughout the brain cortex, but some
regions have higher numbers (Lawson et al., 1990 ). Particularly
interesting is their abundance in the hippocampus, which is highly
susceptible to cerebrovascular insults that rapidly activate microglia
(Wu and Ling, 1998 ). They are present from embryonic to adult stages but at higher density in the adult (Milligan et al., 1991 ; Wu et al.,
1993 ; Ogura et al., 1994 ), attributable in part to proliferation after
birth. Because microglia proliferation is one outcome of CNS injury
(Gehrmann et al., 1995 ; Streit and Kincaid-Colton, 1995 ), it is one
function we are interested in controlling.
Roles of potassium channels in nonexcitable cells, including microglia,
are not well understood, but some cells use
K+ channels for proliferation (for review,
see Dubois and Rouzair-Dubois, 1993 ; Lewis and Cahalan, 1995 ). The
channels needed for proliferation have not been identified except in
lymphocytes where Kv1.3 (Lewis and Cahalan, 1995 ) and a
Ca2+/calmodulin-activated
K+ channel (hSK4) (Khanna et al., 1999 )
are important. Although we have shown that microglia proliferation
involves anion channels (Schlichter et al., 1996 ), roles of microglial
K+ channels and their molecular identities
are not known. Interestingly, Kv1.3 mRNA is present in cultured
microglia. They express a current that resembles Kv1.3 both
biophysically and pharmacologically (Norenberg et al., 1994 ; Schlichter
et al., 1996 ; Eder, 1998 ), and there is some immunocytochemical
evidence for Kv1.5 protein (Pyo et al., 1997 ; Jou et al., 1998 ).
The expression of Kv currents in microglia is highly variable, but the
reasons for and the consequences of this variability are poorly
understood. Almost all studies use cultured microglia from
enzymatically dissociated neopallial tissue, thus removing cell-cell
contacts and secretion products (e.g., growth factors from astrocytes)
that might affect Kv expression. Here, we developed a "tissue
print" method for studying microglia in vitro without enzymatic dissociation. Conventional hippocampal brain slices were
first adhered to substrate-coated glass coverslips, then peeled away to
isolate a monolayer of CNS cells that retained an organotypic
distribution. Many of the microglia and astrocytes retained
morphologies typical of those seen in vivo. Our goals were
to characterize the Kv current in hippocampal microglia and determine
whether it is involved in proliferation. Surprisingly, we found two Kv
currents the prevalence of which changed in vitro and
correlated with the cells' proliferative state. Kv1.3 and Kv1.5
protein were present, and the changes in current type corresponded with
changes in their expression at the cell surface. Most significantly, both currents were involved in microglia proliferation, but their relative roles changed with time in culture.
Part of this work was published previously in abstract form (Kotecha
and Schlichter, 1998 ).
 |
MATERIALS AND METHODS |
Preparing tissue prints. Wistar rats (Charles River,
Quebec) were decapitated on postnatal days 5-14 (P5-14) in
accordance with the Canadian Guidelines for Animal Care and
Experimentation. After the head was sterilized in 75% ethanol for
~10 sec, the brain was dissected aseptically into cold artificial
CSF (aCSF, 4°C), which was bubbled with carbogen (95%
O2, 5% CO2). During dissection, we used a low-Ca2+,
high-Mg2+ sucrose aCSF
(low-Ca2+ aCSF) that contained (in
mM): 26 NaHCO3, 3.25 KCl, 0.1 CaCl2, 4 MgCl2, 1.25 KH2PO4, 10 D-glucose, 200 sucrose, with a pH of 7.4 and osmolarity of
285 mOsm. All chemicals were from Sigma (St. Louis, MO) unless stated
otherwise. The cerebellar lobes were removed, and the brain was
attached with cyanoacrylate glue (cut surface down) to a cold metal
block. Low-Ca2+ aCSF was perfused over the
brain throughout the dissection, which was completed within 3 min.
Carbogen bubbling was stopped briefly, and 200- to 250-µm-thick
hippocampal slices were cut with a Vibratome (series 1000, Pelco
Instruments, Aggwam, MA) directly into cold low-Ca2+ aCSF. In preparation for tissue
printing, the hippocampal slices were transferred to sucrose aCSF that
contained 1.5 mM calcium. The tissue print procedure was
modified from Kotecha et al. (1997) to study microglia from the
hippocampal formation. Each hippocampal slice was transferred to a pure
nitrocellulose membrane (0.45-µm-diameter pores; Bio-Rad, Hercules,
CA) that was inverted onto a sterile coverslip that had been coated
with poly-L-lysine (1 mg/ml, >300,000 molecular weight)
and rat-tail collagen (1.5 mg/ml). The coverslip was placed in a 35 mm
Petri dish and briefly centrifuged (700 rpm, <1 min) before 2.5 ml
culture medium was added; i.e., Minimum Essential Medium (MEM), 5%
fetal bovine, 5% horse serum, and 50 µg/ml gentamycin (all from Life
Technologies, Grand Island, NY). After they were incubated for at least
2 hr (95% O2, 5% CO2,
37°C), each hippocampal slice and nitrocellulose membrane was peeled away with fine forceps, leaving tissue-printed cells on the coverslip. These cells were either used the same day (zero days in culture, "0
DIC") or cultured up for to 15 d, during which time ~2 ml of medium was replaced by fresh culture medium every 2 d.
Purified microglia cultures. Highly purified microglia from
neopallia of neonatal rat pups (P1-2) were prepared as described previously (Schlichter et al., 1996 ). Briefly, neopallial tissue was minced in cold MEM, transferred to a dissociation medium of MEM
with 0.25% trypsin (Sigma) and 100 U/ml DNase I (Pharmacia Biotech,
Toronto), then agitated (30 min, 37°C) using a magnetic stir plate,
gently triturated, and agitated again. After dissociation, the mixture
was pelleted, resuspended in MEM, passed through a cell strainer
(40-µm-diameter holes), and seeded in 75 cm2 flasks in 30 ml of culture medium, as
above. After 12 d in culture without feeding, the floating cells
(>95% microglia) were transferred to a new flask and incubated for 1 hr at 37°C, and the adherent cells (98-100% microglia) were
harvested. These cells were used for Western blot analysis to test for
the presence of Kv1.3 and Kv1.5 proteins and for RT-PCR to assay for
mRNA for several Kv channels.
Identifying microglia. Hippocampal tissue prints contained
microglia, astrocytes, and fibroblasts. We used several markers to
discriminate microglia in living or fixed tissue prints. OX-42 antibody
binds to the CR3 complement receptor (Damoiseaux et al., 1994 ), and ED1
antibody (both from Vector, Burlingame, CA) is specific for a protein
located on the membrane of lysosomes (Dijkstra et al., 1985 ). In the
brain, both antigens are restricted to microglia (Dijkstra et al.,
1985 ). Isolectin B4 (Sigma) binds to the external membrane of microglia at -D-galactose residues (Streit
et al., 1988 ), and because fluorescent-conjugated forms are available it can be used to label living or fixed cells. In fixed tissue, we
stained astrocytes with an antibody directed against glial fibrillary
acidic protein (anti-GFAP) (Sigma) and fibroblasts with
anti-fibronectin antibody (Chemicon, Temecula, CA). Before labeling,
tissue prints were washed with PBS using a standard protocol of three
washes for 5 min each. Live microglia were labeled by incubating tissue
prints for 20 min in a 1% solution of Texas Red-conjugated
IB4 in PBS, followed by washing in PBS (3 times, 5 min each). When required, tissue prints were incubated for 20 min in
cold methanol on dry ice ( 20°C) to rapidly fix and permeabilize the
cells. For antibody labeling, subsequent steps were performed at room
temperature unless indicated. After the fixed tissue prints were washed
in PBS they were incubated for several hours in 10% bovine serum
albumin (BSA) or 10% skim milk as blocking agents. The primary
monoclonal antibody, either OX-42 (1:200 dilution) or ED1 (1:100), was
added in a 1% BSA solution and incubated overnight at 4°C. The
tissue prints were then washed in 5% BSA, incubated for 3 hr in
biotinylated rabbit anti-mouse secondary antibody (1:100, Vector), and
washed again in 5% BSA. Finally, the fixed tissue prints were
incubated for 1 hr in a 1% BSA solution containing FITC-conjugated
streptavidin secondary antibody (1:100, Vector), then washed, first
with 5% BSA and then with PBS. For each negative control, the primary
antibody was omitted. All stained slides were treated with SlowFade
(Molecular Probes, Eugene, OR) and stored in the dark at 4°C. To
further reduce the background staining of regions devoid of microglia,
multiple washes in a high concentration of blocking agent were performed.
In living tissue prints, microglia viability was determined with the
LIVE/DEAD assay (Molecular Probes) in which calcein-AM accumulation and
cleavage by cytosolic esterases label live cells and ethidium bromide
labels the nuclei of dead cells. Tissue prints were washed with PBS,
then incubated for 30 min in PBS containing 2.0 µM
calcein-AM and 4.0 µM ethidium bromide, and washed again with PBS. For analysis of cell phenotype, morphology, and viability, tissue prints were viewed using an inverted microscope (Olympus IMT-2)
fitted with epifluorescence and Hoffman Modulation optics. Images were
digitized using a CCD camera (Cohu, San Diego, CA) and Axon Imaging
Workbench software (ver. 2.1, Axon Instruments, Foster City, CA).
Electrophysiology. Before recording, tissue prints on
coverslips were washed several times in extracellular solution that contained (in mM): 125 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, pH 7.4 (adjusted with NaOH). The osmolarity (300 mOsm) was adjusted using sucrose and measured with a freezing point depression osmometer (model 3MO, Advanced Instruments, Norwood, MA). The pipette
(intracellular) solution contained (in mM): 100 K-aspartate, 40 KCl, 1 MgCl2, 1 CaCl2 (15 nM free
Ca2+), 10 HEPES, 2 K2ATP, 10 EGTA, pH 7.2 (adjusted with KOH), 300 mOsm. By eliminating the osmotic gradient, the volume-sensitive anion
current (Schlichter et al., 1996 ) was reduced to <50 pA at voltages
where Kv currents were active (remaining anion current can be seen in
Fig. 2B). During patch-clamp recordings the
small-volume bath chamber (150 µl) (Model RC-25, Warner Instruments,
Hamden, CT) was continuously perfused at 1-2 ml/min using a gravity feed.
All patch-clamp recordings were made at room temperature (20-25°C)
in the whole-cell configuration using an Axopatch 1D amplifier (Axon),
and pipettes were pulled from borosilicate glass (WPI, Sarasota, FL).
The patch-clamp circuit was used to filter the currents (5 kHz) and to
compensate capacitive transients and series resistance, unless
otherwise indicated. We did not compensate for "leakage" currents,
so we could monitor changes in voltage- and time-independent currents,
especially Cl current. For most
recordings the pipette resistance was 5-7.5 M , and the maximal
uncompensated series resistance error was 10 mV. For faster voltage
clamping to determine current activation kinetics, we used thin-walled
borosilicate glass (WPI) to pull 1-2 M resistance pipettes.
Voltages were applied, and currents were recorded using pCLAMP software
(ver. 6.0, Axon) and Tecmar Labmaster data acquisition boards. Data
were stored on computer and analyzed using Origin (ver. 5, Microcal,
Northampton, MA). All reversal potentials and current versus voltage
relations were corrected for junction potentials among the bath,
pipette, and ground agar bridge solutions.
The pharmacological profile of the Kv currents was tested using the
small-volume perfusion chamber with a three-port manifold, which
required <30 sec for complete bath exchange. The broad-spectrum K+-channel blockers 4-aminopyridine (4-AP)
and tetraethylammonium (TEA) were from Sigma. The peptide toxins
(charybdotoxin, margatoxin, agitoxin-2) were obtained from Alomone Labs
(Jerusalem, Israel), stored lyophilized at 20°C, then made up in
extracellular solution containing 0.1% BSA to reduce drug adsorption
onto perfusion lines or the glass-bottomed chamber. Current inhibition
is expressed as mean ± SEM. Throughout this paper the statistical
significance (p < 0.05) was tested using
Student's t tests.
Proliferation assay. The same assay was used to determine
the percentage of tissue-printed microglia that were proliferating at
different times in culture and the proliferative state of individual microglia from which patch-clamp recordings were made: incorporation of
the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) into DNA. Before
electrophysiological recordings, tissue prints were incubated in MEM
containing 1 mg/ml BrdU substrate (12 hr, 95%
O2, 5% CO2, 37°C). Then,
during patch-clamp recording the pipette contained the fluorescent dye
Lucifer yellow (0.4 mg/ml), which diffused into and marked the cell
from which a recording was made. After characterizing the
K+ currents in a microglia cell, the patch
pipette was slowly withdrawn to allow healing and prevent dye loss,
then the entire dish was fixed in cold methanol for 20 min (as above).
The tissue print was washed (PBS, 3 times, 5 min each) and incubated in
4 M HCl for 20 min to fragment the DNA, thereby exposing
BrdU sites. After five more washes in PBS to neutralize the pH, the
tissue print was incubated (24 hr, 4°C) in a 1% skim milk solution
containing a monoclonal anti-BrdU antibody (1:1000; Sigma). The tissue
print was then washed with 5% skim milk, incubated with biotinylated anti-mouse secondary antibody (1 hr, 1:100 dilution; Vector), and
washed again with 5% skim milk. Finally, the tissue print was
incubated for 1 hr in a 1% BSA solution containing Texas
Red-neutravidin-conjugated streptavidin antibody, washed with 5% BSA,
then washed with PBS. The coverslip containing the stained tissue print
was mounted on a glass slide and viewed under fluorescence optics,
first with a FITC filter to locate the Lucifer yellow-filled cell, then
with a Cy3 filter to determine whether the cell was BrdU positive.
To quantify microglia proliferation in tissue prints after 0, 5, and 10 DIC, BrdU substrate was added 12 hr before the cells were fixed,
permeabilized, and labeled with anti-BrdU antibody (as above). For
tissue prints grown for 5 and 10 DIC, the standard culture medium (with
or without K+-channel blockers) was
changed every 2 d. Microglia were surface-labeled by incubating
for 20 min in a 1% solution of IB4 conjugated to FITC (Sigma), followed by washing (5 times) in PBS. A field of cells
was viewed under an FITC filter to identify all microglia, then with a
Cy3 filter to determine whether the nucleus stained with anti-BrdU
antibody. The percentage of microglia that were proliferating was the
proportion of IB4-positive cells with
anti-BrdU-positive nuclei.
Immunocytochemical labeling of Kv1.5 and Kv1.3 proteins on
tissue-printed microglia. We used two-color immunofluorescence and
confocal microscopy to identify Kv1.3 or Kv1.5 proteins in tissue-printed microglia. A scanning confocal microscope (Bio-Rad MRC-600) equipped with an argon ion laser, fluorescein and Cy3 filter
sets, and a 60× objective was used to visualize the subcellular location of each antibody (membrane vs cytosol). To allow
superimposition of fluorescence images showing OX-42 and
K+ channel staining, the same gain and
focal plane were used. For all experiments, the concentrations of
antibodies, fluorescence intensity gain, and pinhole and neutral
density filters were kept constant. Digitized images were prepared
using the software provided with the confocal microscope and Adobe
Photoshop (ver. 4.0, Adobe Systems, Mountainview, CA). Cells were fixed
and prepared for antibody staining as described above, using OX-42 to
label microglia. The affinity-purified polyclonal anti-Kv1.5 antibody
(1:200, Upstate Biotechnology, Lake Placid, NY) has been previously
characterized as specific for Kv1.5 in glial cells (Sobko et al.,
1998 ). We used an anti-Kv1.3 antibody (1:100) made by Dr. James
Douglass (Vollum Institute, Portland, OR) and kindly provided by Dr.
I. B. Levitan (Brandeis University, Waltham, MA). The
rabbit polyclonal serum was raised against a MalE fusion protein
containing a sequence specific to an intracellular region of Kv1.3 (Cai
and Douglass, 1993 ). This antibody has been well characterized and was
found to be specific for Kv1.3 and useful for immunofluorescence and Western analysis (Fadool et al., 1997 ).
Although both antibodies have been previously characterized, we
performed several control experiments. To ensure that there was no
cross-reactivity between the Kv antibodies, we heterologously expressed
each channel in a rat microglia cell line (MLS-9, developed in our lab)
(Zhou et al., 1998b ) that does not express either channel. After
growing MLS-9 cells in flasks to >60% confluency, they were
co-transfected (Lipofectamine, Life Technologies) with full-length
cDNAs encoding either Kv1.3 or Kv1.5 (2 µg cDNA per 35 mm dish) and
the marker, enhanced green fluorescent protein (1 µg cDNA per dish;
Clontech, Palo Alto, CA). Transfection efficiency, monitored as
percentage of green fluorescent cells, was 50-75%. Labeling with each
Kv primary antibody and Cy3-conjugated (red) secondary antibody was
performed 2 d after transfection, as described above. Each
antibody brightly stained cells that were transfected with the channel
against which the primary antibody was directed (see Fig. 7). In
contrast, anti-Kv1.3 did not label Kv1.5-transfected cells, and
anti-Kv1.5 did not label Kv1.3-transfected cells; thus the Kv
antibodies were specific. The preimmune serum for the Kv1.3 antibody
did not stain either Kv1.3- or Kv1.5-transfected MLS-9 cells, and there
was no staining when either primary antibody was omitted.
Western blot analysis. Each type of cell or tissue (primary
cultured microglia, rat heart, HEK-293 cells) was lysed in ice-cold solubilization buffer containing protease and phosphatase inhibitors: 25 mM Tris, pH 7.5, 150 mM NaCl, 100 mM NaF, 5 mM EDTA, 1 mM
Na3VO4, 1% Triton X-100
(Sigma), 1 µg/ml leupeptin, 2 µg/ml aprotinin, and 1 mM
phenylmethylsulfonyl fluoride. The lysate was triturated, then
centrifuged (15,000 × g, 5 min, 4°C) to remove any
cellular debris, and the membrane-enriched supernatant was retrieved.
Total protein concentration was determined with a Bio-Rad DC Protein Assay (Bio-Rad, Mississauga, Ontario) with bovine serum albumin as the
standard. Proteins (15 µg/lane) were resolved on a 10% acrylamide
gel by SDS-PAGE, then electrotransferred to nitrocellulose, blocked in
5% nonfat milk, and incubated overnight at 4°C with a primary
antibody (same antibodies as for immunocytochemistry, above): either
Kv1.3 (1:20) or Kv1.5 (1:350). Blots were incubated with horseradish
peroxidase-conjugated secondary antibody (Cedarlane, Hornby, Ontario)
for 1 hr at room temperature. Enhanced chemiluminescence (Amersham,
Arlington Heights, IL) on XAR-2 film (Kodak, Rochester, NY) was used to
visualize labeled proteins. Unless specified otherwise, reagents for
Western immunoblotting were from Sigma.
RT-PCR. Total RNA was isolated from cultured microglia using
the guanidinium isothiocyanate method (Sambrook et al., 1989 ) and
subjected to DNase I digestion (Pharmacia; 0.1 U/ml, 15 min, 37°C) to
eliminate genomic contamination. First-strand cDNA was synthesized
according to the manufacturer's instructions (Pharmacia) using an
oligo-dT-based primer. The cDNA was then used as a template for PCR
reactions using gene-specific primers: Kv1.1 (GenBank accession no.
M30439), Kv1.2 (J04731), Kv1.3 (M30312), Kv1.4 (M32867), Kv1.5
(M27158), Kv1.6 (U45979), actin (M12481), and S16 ribosomal RNA
(M11409). The PCR reaction was conducted with 1.5 mM
MgCl2, 0.5 M forward and reverse
primers, and 10% of the cDNA reaction mixture, using a Minicycler
system (MJ Research, Watertown, MA) and 1.25 U of Taq DNA
Polymerase (BioBasic, Toronto). The PCR-amplified DNA fragments were
resolved in 2% agarose gels containing 0.5 mg/ml ethidium bromide. The identities of products of the predicted sizes were confirmed by restriction endonuclease digestion or by sequencing.
 |
RESULTS |
Optimizing the tissue-printing procedure for microglia
The method for preparing tissue prints from brain (Kotecha et al.,
1997 ) was modified to obtain large numbers of healthy microglia with
small cell bodies and one or more long processes. In the rat, there are
relatively few microglia before P2, but they are numerous by P12
(Milligan et al., 1991 ). The hippocampus was used because it contains
many microglia, is important from a pathological point of view (e.g.,
stroke), and the considerable electrophysiology data on hippocampal
neurons and astrocytes should prove useful in future studies of
microglia-neuron-astrocyte interactions. We tested different aCSF
compositions, ages of rats, and substrates applied to the coverslip.
Use of cold (4°C) aCSF with low Ca2+,
high Mg2+, and sucrose (see Materials and
Methods) facilitated the isolation of many viable microglia with small
spindle-shaped cell bodies and one or two processes up to 20 µm long,
but fewer microglia were obtained at room temperature. Tissue prints
prepared in aCSF with "normal" Ca2+
(1-2 mM) and 125 mM NaCl contained both
neuronal and non-neuronal cells, but most were swollen and pyknotic,
cell numbers were low, and microglia progressed from small and round to
large and granular after several days in culture. All results in this
paper are from young rats (P5-14) because many spindle-shaped
microglia with long processes were present, whereas few microglia were
obtained from older animals (P20-25).
Tissue prints favoring particular brain cells are made by exploiting
specific cell-substrate interactions (Kotecha et al., 1997 ). We tested
several "adhesive" substrates and, as indicated in Table
1, the most successful method used
poly-L-lysine (1 mg/ml) and rat tail collagen (1.5 mg/ml).
With this method the cells retained an apparently normal organotypic
distribution; for instance, the hippocampus could be clearly
distinguished when viewed at low power using Hoffman modulation
contrast optics. Because many microglia were tissue-printed and they
retained one or more long processes (Fig.
1A) for several days in
culture (Fig. 1B), this method was used for the
remainder of the study. Two other methods were extensively tested
(12-18 experiments each), found to be less successful, and rejected.
That is, coverslips coated with poly-L-lysine (1 mg/ml), concanavalin A (Con A, 0.5 mg/ml) and laminin (10 µg/ml)
allowed many microglia to be isolated, but they were large and
granulated and proliferated rapidly, possibly having been activated by
laminin or Con A (Chamak and Mallat, 1991 ). When
poly-L-lysine (1 mg/ml) and Con A (2 mg/ml) were
used, numerous non-neuronal cells were isolated, and the microglia at first retained long processes; however, within 2 d they became round, granular, and highly proliferative.

View larger version (104K):
[in this window]
[in a new window]
|
Figure 1.
Morphology and phenotype of tissue-printed
microglia from rat pups. A, Bright-field image of a
freshly prepared tissue print made from a hippocampal slice on a
coverslip coated with poly-L-lysine and rat-tail collagen
(see Materials and Methods). The arrow indicates a
bipolar microglia cell that is surrounded by extracellular matrix and
other cells, including large, flat astrocytes. Scale bar (shown in
A for A and B): 50 µm.
B, Changes in microglia morphology in culture. A typical
hippocampal tissue print after several days in culture, showing
increased numbers of microglia and two prevalent morphologies: unipolar
or bipolar with long processes (arrows) and numerous
rounded, granular cells. All patch-clamp recordings were made from
unipolar or bipolar microglia. C, D,
Fluorescence images of isolated microglia that were fixed before
labeling with Texas Red-conjugated isolectin B4
(IB4) (C) or
OX-42 antibody with an FITC-conjugated secondary antibody
(D). Scale bar (shown in
C for C and D): 20 µm.
|
|
Morphology and phenotype of tissue-printed microglia
Four microglia morphologies were seen in tissue prints.
Immediately after the tissue prints were prepared (Fig.
1A), most microglia had a small, elongated cell body
and one or two long processes (more than two times longer than the
width of the cell body). A few microglia were ramified with multiple
branched processes (data not shown). When tissue prints were cultured
(Fig. 1B), the prevalence of different microglia
morphologies changed, with fewer ramified, unipolar, or bipolar cells
(data not shown) and more with uropod- or lamellipod-like processes, or
spherical, granular cell bodies without processes. After 5-15 DIC the
appearance of the entire tissue print also changed. The remaining
viable cells (microglia, fibroblasts, astrocytes) tended to cluster
with the same cell type, and the organotypic appearance of the
hippocampus was gradually lost. Consistent with previous studies of
hippocampal slice organotypic cultures (Hailer et al., 1996 ), microglia
gradually activated during culturing and tended to migrate to the
periphery of the tissue print. Despite these changes, bipolar and
unipolar (Fig. 1B) microglia were always present
throughout the tissue print, and only these cells were selected for
patch-clamp recordings.
To confirm the identity of tissue-printed cells morphologically
identified as microglia, we used monoclonal antibodies on fixed cells
(OX-42, ED1), and the lectin, IB4, on living or
fixed cells. The specificity of these markers was tested on highly
purified rat microglia cultures (Table
2), wherein 95-100% of cells stained with IB4, ED1, or OX-42. Fewer than 4% of the
cultured cells stained with anti-GFAP (astrocytes) or anti-fibronectin
(fibroblasts), compared with 50-75% of the cells in tissue prints.
IB4 (Fig. 1C) and OX-42 (Figs.
1D, 8) selectively stained microglia, and labeling
was restricted to the membrane. ED1, which labeled only microglia, did
so in a punctate pattern that was restricted to the cytosol (data not
shown). IB4 staining of microglia was
consistently intense throughout the culture period, whereas OX-42 and
ED1 staining were lower on bipolar cells (most cells in early cultures)
than on spherical microglia (predominant in late cultures). This result corresponds with earlier studies in which ED1 and OX-42 staining were
low on ramified microglia but high on amoeboid or activated cells
(Dijkstra et al., 1985 ; Graeber, 1993 ).
Expression of voltage-gated K+ currents declines with
time in culture
With experience, using the labeling protocols (above), it became
simple to recognize unipolar, bipolar, and spherical microglia from
their morphology using Hoffman optics and a 40× objective. Nevertheless, after >20 patch-clamp recordings of unipolar and bipolar
cells, we perfused the dish with Texas Red-conjugated IB4 and confirmed that the cells recorded from
were microglia. To favor Kv currents, the holding potential was very
negative to prevent channel inactivation, internal
Ca2+ was low to eliminate
Ca2+-activated
K+ currents, and osmolarities were
balanced to avoid activating swelling-sensitive
Cl currents (Schlichter et al.,
1996 ).
When tissue prints were cultured, the expression of Kv currents
decreased dramatically with time in culture. For convenience, we
defined three culture periods: 0-5 DIC, 6-10 DIC, and >10 DIC. Distinct Kv currents (>20 pA) were seen in >95% (61 of 63) of microglia after 0-5 DIC, in significantly fewer microglia (52%, 26 of
50 cells; p < 0.001, 2
test) after 6-10 DIC, and <20% of microglia after >10 DIC (8 of 42;
p < 0.0001, 2 test).
In addition, for those microglia expressing Kv currents, the current
density decreased with time in culture, from 93.8 ± 10.6 pA/pF
(n = 61, 0-5 DIC) to 76.2 ± 21 pA/pF
(n = 26, 6-10 DIC) and 31 ± 9.5 pA/pF
(n = 8, >10 DIC). The whole-cell capacitance was
18.4 ± 3.0 pF, with a range of 8-44.5 pF (n = 75). Decreases in current density were significant at 6-10 and >10
DIC (p < 0.001). Finally, and very importantly,
the type of Kv current changed in culture, as judged from changes in
biophysical and pharmacological properties (described below).
Biophysical properties of the Kv currents
For comparison of biophysical and pharmacological properties (and
Kv channel protein expression; see below), microglia were examined at
0-5 DIC and compared with >10 DIC tissue prints. At all times, the
voltage-activated currents were highly K+
selective, because the reversal potentials were between 80 and 84
mV, which is very close to the calculated Nernst potential for
K+ ( 85 mV) for the
K+ concentrations used. Reversal
potentials for other ionic species in these solutions were
ECl = 20 mV,
ECa = >100 mV,
EH = +15 mV. Kv currents in microglia
in tissue prints cultured from 0-5 d (Fig.
2) activated at approximately 65 mV and
increased in amplitude with depolarization. As is typical of Kv
currents, the voltage dependence of activation and steady-state
inactivation were well described by Boltzmann functions (Fig.
2C), with the derived parameters as indicated in the legend.
The voltages producing half-maximal conductance
(V1/2) were approximately 10 mV
for activation (fully activated at approximately +30 mV) and 29 mV for inactivation. Steady-state inactivation began at approximately 70
mV and was complete at ~0 mV. The region under the intersection of
activation and inactivation curves predicts a window of tonic channel
activity between 65 and 0 mV, with maximal activity at the
intersection voltage of 20 mV. The slope factors
(kn) of the Boltzmann curves
(mV/e-fold change in conductance) were ~14 mV for activation and ~9
mV for inactivation. The Kv currents in most microglia during this time
period exhibited very little inactivation. Sustained depolarizing steps
were used to examine the inactivation time course, which was well
described by a monoexponential function (Fig.
3B) and was nearly independent
of voltage, except at the most negative potentials (Fig.
3D). In some cells, the degree of steady-state inactivation
was more pronounced at positive potentials (Fig. 2A),
and this property increased with time in culture, as described below.
Table 3 compares key biophysical and
pharmacological features of Kv currents in tissue-printed microglia
with those of cultured microglia, Kv1.5 and Kv1.3 channels.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 2.
Voltage dependence of microglia Kv currents.
A, Early culture (0-5 DIC): whole-cell currents from a
bipolar microglia cell after 3 DIC, recorded during 500 msec steps
(from 90 to +150 mV in 20 mV increments) from a holding potential of
100 mV. To ensure complete recovery from inactivation, successive
voltage-clamp steps were separated by 60 sec. B,
Steady-state inactivation was measured by varying the holding potential
( 80 to +10 mV), waiting 2 min at each voltage, then applying a 100 msec test pulse to +30 mV. When the cell was held at potentials
positive to 20 mV, there was no Kv current (a small anion current
remains; see Materials and Methods). C, Average
conductance versus voltage relations, calculated from
g = Ipeak/(V EK), for activation and steady-state
inactivation of Kv currents from early (0-5 DIC) and later cultures
(6-10 DIC). The voltage dependencies were fitted to Boltzmann
equations of the form
g/gmax = 1/(1 + exp
V V1/2/kn),
from which the voltage for half-maximal activation
(V1/2) and the slope factor
(kn) were calculated. For 0-5 DIC
cells: activation V1/2 10.3 ± 2.6 and kn 13.9 ± 2.4 (n = 10), inactivation
V1/2 29.4 ± 2.4 and
kn 8.8 ± 2.1 (n = 7). For 6-10 DIC cells (n = 8): activation
V1/2 27.1 ± 3.0 and
kn 11.1 ± 3.1, inactivation
V1/2 38.2 ± 3.4 and
kn 9.1 ± 3.8. D,
Reversal potential (Erev) of the
voltage-activated outward current indicates a high
K+ selectivity. Each 50 msec step to +20 mV was
followed by a test pulse between 50 and 130 mV (20 mV increments).
The tail current reversed at 84 mV, which was essentially the same as
EK ( 86 mV) for the solutions used.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Figure 3.
Inactivation kinetics of the Kv currents.
A, Representative currents from a microglia 2 d
after preparing the tissue print. Currents in response to a series of
voltage-clamp steps were each fitted to a monoexponential function
(smooth curves) to obtain the inactivation time
constant. B, Typical currents from a tissue-printed
microglia maintained in culture for several days. A monoexponential
function was fitted to the falling phase beginning after each current
peak. C, Time constant ( , mean ± SEM) for
inactivation in 0-5 DIC cells (n = 8) and 6-10
DIC cells (n = 6) as a function of membrane
potential.
|
|
View this table:
[in this window]
[in a new window]
|
Table 3.
Comparison of Kv currents in tissue-printed microglia with
Kv1.5, Kv1.3, and the Kv current in dissociated, cultured microglia
|
|
After >5 DIC, properties of the Kv current in those microglia with
detectable currents changed from the current described above.
Voltage-dependent activation was present above approximately 70 mV,
with complete activation at approximately +30 mV, but the
V1/2 values shifted to more negative
potentials than those of 0-5 DIC microglia (Fig. 2C). More
striking was the increase in cumulative inactivation with time in
culture. Cumulative inactivation occurs when recovery from inactivation
between test pulses is sufficiently slow to be incomplete by the start
of the next pulse (Grissmer et al., 1994 ; Lewis and Cahalan, 1995 ).
This property is particularly pronounced in Kv1.3 channels, occurring
even with interpulse intervals of 60-90 sec (Pahapill and Schlichter,
1990 ; Chung and Schlichter, 1997 ). Other Kv channels, including Kv1.5, display little if any cumulative inactivation, even at intervals as
short as 1 sec (Grissmer et al., 1994 ) (Table 3). The data in
Figure 4 show that microglia Kv currents
are increasingly susceptible to cumulative inactivation as tissue
prints are cultured. From 0-5 DIC no cumulative inactivation was seen
even when the interpulse interval was 5 sec (Fig. 4D)
(n = 35); that is, each successive test pulse produced
the same current amplitude (Fig. 4A). However, after
6-10 DIC there was some cumulative inactivation with 30 sec intervals,
and significantly more at 15 sec intervals than in microglia at 0-5
DIC (Fig. 4D) (p < 0.002, n = 21). With 10 sec intervals, inactivation
accumulated between the first and second pulses, then reached
steady-state (Fig. 4B). For tissue prints >10 DIC
(Fig. 4C) (10 sec intervals), inactivation was progressively
increased by the first five test pulses, then steady-state was reached.
For all interpulse intervals tested, cumulative inactivation in >10
DIC cells was significantly greater than in 0-5 or 6-10 DIC cells
(Fig. 4D) (p < 0.001, n = 8). The steady-state level of cumulative
inactivation also increased with time in culture; i.e., with 0.2 Hz
stimulation the Kv current reached steady-state at 47% (6-10 DIC) and
21% (>10 DIC) of the initial amplitude. For comparison, in cultured
microglia stimulated at 1 Hz, the Kv current declined to ~40%
(Norenberg et al., 1994 ) or ~25% (Schlichter et al., 1996 ) of the
control value.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 4.
Cumulative inactivation of microglial Kv currents
is acquired with time in culture. A-C,
From a holding potential of 100 mV, each cell was stepped to +20 mV
from four to six times (numbered in sequence) with an interpulse
interval of 10 sec. Typical recordings are shown from microglia in
tissue prints at early (1 DIC), intermediate (7
DIC), and late (12 DIC) times in culture.
D, Summary of responses to repetitive pulses with varied
interpulse intervals. For each cell and at each interpulse interval
(progressing from longest to shortest), repetitive test pulses were
applied until there was no further change in current. Data are
normalized as I/Imax,
where Imax is the peak current during the
first test pulse, and expressed as mean ± SEM. Significant
differences in the degree of cumulative inactivation between 0-5 DIC
and 6-10 DIC are indicated (*), as are differences between 6-10 DIC
and >10 DIC cells ( ).
|
|
Pharmacological profile of Kv currents
The changes in voltage dependence and cumulative inactivation that
occurred with time in culture raised the possibility that a change in
Kv current type occurs. Because pharmacological profiles can help
identify or eliminate channel types, we first tested the broad-spectrum
K+ channel blockers 4-aminopyridine (4-AP)
and tetraethylammonium (TEA) (Grissmer et al., 1994 ; Chandy and Gutman,
1995 ; Mathie et al., 1998 ), as well as BaCl2,
which potently blocks the inward rectifier (Norenberg et al., 1994 ;
Schlichter et al., 1996 ). Peptide toxins, which are more potent and
selective, can be useful in discriminating among Kv channel types. We
tested charybdotoxin (ChTx), which blocks several Kv channels
(including Kv1.3) at nanomolar concentrations (Grissmer et al., 1994 ;
Chandy and Gutman, 1995 ; Garcia et al., 1997 ; Mathie et al., 1998 ),
margatoxin (MgTx), which potently blocks Kv1.3 and less potently
inhibits several other Kv channels (Spencer et al., 1997 ), and
agitoxin-2 (AgTx-2), which is an extremely potent Kv1.3 blocker (Garcia
et al., 1997 ). Before evaluating drug effects, we determined that
corrections for Kv current rundown were unnecessary. The current
amplitude declined <5% in the first 10 min after establishing a
whole-cell recording and <10% after 30 min (Fig.
5A); thus to avoid rundown we
completed each experiment within 10 min. Control Kv currents were
recorded from each cell before the desired concentration of drug was
rapidly perfused into the small-volume recording chamber. This ensured
a uniform concentration within 30 sec (see Materials and Methods);
nevertheless, we waited 2-3 min before testing the response to drug,
then repeated voltage-clamp steps until steady-state block was attained
at that concentration.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 5.
Pharmacological profile of microglia in early
tissue print cultures (0-5 DIC). A, Current rundown was
assessed by applying voltage steps to 30 mV from a holding potential
of 100 mV every 5 min after establishing a whole-cell recording.
Normalized values are
I/Imax, where
Imax is the peak current attained during the
first voltage-clamp step, expressed as mean ± SEM
(n = 4). B, Average inhibition of Kv
currents in early cells by several K+-channel
blockers. Channel block was assessed during voltage-clamp steps ranging
from 50 to +50 mV, within the first 10 min after establishing each
whole-cell recording. Bars represent mean ± SEM (number of
experiments), and paired t tests were used because each
cell acted as its own control.
|
|
Kv in microglia at 0-5 DIC
Effects of K+-channel blockers are
summarized in Figure 5B. TEA was tested at 5 mM, because this concentration blocks >50% of
several Kv currents, including Kv1.1 and 1.6, Kv2.1 and 2.2, and Kv3.1
to 3.4 (Grissmer et al., 1994 ; Mathie et al., 1998 ). In early
tissue-printed microglia, 5 mM TEA inhibited the
Kv current by 18 ± 7% (n = 3). 4-AP reduced the
Kv current by 42 ± 9% at 1 mM
(p < 0.001, n = 3) and by
21 ± 12% at 250 µM
(p < 0.002, n = 3; data not
shown), whereas 10 mM BaCl2
had no effect. ChTx, which was tested at high enough concentrations to
affect several Kv currents (Grissmer et al., 1994 ; Chandy and Gutman,
1995 ), reduced the microglia current by 27 ± 14% at 10 nM and 43 ± 21% at 50 nM (n = 4 each). Block by ChTx
was voltage- and time-independent, and the remaining current was
confirmed as a Kv current with similar time- and voltage-dependent
activation, reversal near EK, and lack
of cumulative inactivation.
Because we were particularly interested in whether Kv1.3 channels
contributed to the microglia Kv current, we tested MgTx and AgTx-2 at
many times the concentration required for 50% block of Kv1.3 channels
(Spencer et al., 1997 ). Even at 5 nM, MgTx failed to
significantly inhibit the Kv current: a voltage-independent decrease of
8 ± 12% (p > 0.2, n = 5)
was seen. AgTx-2 did not inhibit the Kv current at either 5 nM (5 ± 8% decrease, p > 0.3, n = 5) or 50 nM (8 ± 4% decrease, p > 0.2, n = 5). To
verify the potency of the AgTx-2 aliquots used, we determined the
Kd for blocking Kv1.3 current in
activated human T lymphocyte, a cell in which Kv1.3 channels exist as
homotetramers (Grissmer et al., 1994 ; Chandy and Gutman, 1995 ). As
expected, AgTx-2 inhibited the lymphoblast Kv1.3 current at all
voltages, and a dose-response curve (n = 4; data not
shown) yielded a Kd of 177 pM and a Hill coefficient of 1.1. Thus, a Kv1.3
current in microglia should have been fully blocked by 50 nM AgTx-2 (>250
Kd).
AgTx-2 sensitivity of Kv increases as tissue prints
are cultured
Because cumulative inactivation of Kv current (a hallmark of
Kv1.3) became progressively more pronounced as tissue prints were
cultured, we asked whether there was a corresponding increase in Kv
sensitivity to AgTx-2 (Fig. 6). This was
the case: the degree of block by AgTx-2 increased with time in culture,
and the current from a microglia at 10 DIC showed 85% inhibition by 5 nM AgTx-2 (Fig. 6A,C).
Currents in microglia at 3-5 DIC were inhibited <15%, compared with
25-58% inhibition after 6-9 DIC and 55-85% inhibition after 10-12
DIC. As expected, microglia with Kv currents that were AgTx-2 sensitive
displayed cumulative inactivation when voltage-clamp steps were
separated by 10 sec intervals (Fig. 6B).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
AgTx-2 sensitivity of Kv currents increases with
time in culture. A, Representative Kv currents from a
microglial cell at 7 DIC. Currents were evoked by steps between 80
and +20 mV (in 20 mV increments) from a holding potential of 100 mV.
AgTx-2 (5 nM) dramatically reduced the current amplitude in
a time- and voltage-independent manner. B, The cell in
A displayed cumulative inactivation with repetitive
pulses (numbered sequentially) to +30 mV (from a holding potential of
100 mV), separated by an interpulse interval of 10 sec.
C, Inhibition of Kv current by 5 nM AgTx-2
was calculated as a percentage of the control current in the same cell.
Each circle represents a different cell. Depolarizing
test pulses from 80 to +20 mV were applied before and after drug
addition. The data were fitted to a linear regression: correlation
coefficient, 0.94.
|
|
Expression of Kv1.5 and Kv1.3 protein
Several features of the current in microglia from early cultured
tissue prints resembled Kv1.5 (Table 3); i.e., the voltage dependence
and kinetics of gating, very slow inactivation during voltage-clamp
steps, lack of cumulative inactivation even with 5 sec interpulse
intervals, and insensitivity to most blockers (except 4-AP). In
contrast, after several days in culture the current resembled
Kv1.3. Therefore, we determined
whether Kv1.5 and 1.3 proteins are expressed in microglia (Fig. 7), and
whether their expression in tissue-printed hippocampal microglia
changes with time in culture (Fig. 8).
For Kv1.5, the Western blots (Fig. 8C) showed a single
appropriate band (~75 kDa) in rat primary microglia grown in highly
purified cultures and in rat heart (positive control) but no band in
nontransfected HEK-293 cells (negative control). The Kv1.3 antibody
(Fig. 8F), which was used at a high concentration
(1:20) because it was weak (made in 1992), identified an appropriate
band at 65 kDa in cultured rat microglia but not in the nontransfected
HEK-293 cells (negative control).

View larger version (97K):
[in this window]
[in a new window]
|
Figure 7.
Specificity of the Kv1.3 and Kv1.5 antibodies. The
rat microglia cell line MLS-9 (Zhou et al., 1998b ) was transfected with
full-length cDNA for either Kv1.3 or Kv1.5 together with enhanced green
fluorescent protein. Each panel shows a fluorescence image using a
rhodamine filter block (left) and a bright-field image
(right) of the same field of cells. Cells shown are from
different flasks from the same MLS-9 culture. A, MLS-9
cells transfected with Kv1.3 cDNA stained brightly with the anti-Kv1.3
antibody. B, Kv1.3-transfected cells did not stain with
the anti-Kv1.5 antibody. Similarly, Kv1.5-transfected cells stained
brightly with the anti-Kv1.5 antibody (C) but not
with the anti-Kv1.3 antibody (D). Scale bar shown
in C for A and C; shown in
D for B and D.
|
|

View larger version (64K):
[in this window]
[in a new window]
|
Figure 8.
Expression of Kv1.5 and Kv1.3 proteins in cultured
tissue-printed microglia. For immunofluorescence, microglia were
labeled with OX-42 primary antibody, which binds to complement
receptors on the cell surface, and a biotinylated secondary antibody
with FITC-conjugated streptavidin (green labeling). A,
B, Kv1.5. Confocal images of representative microglia
from an early culture (A, 2 DIC) and an
intermediate culture (B, 8 DIC) labeled
with a polyclonal anti-Kv1.5 antibody and a Cy3-conjugated secondary
antibody (red regions). Superimposed images from the
same confocal planes show colocalization (yellow
regions) that is prominent in B. Scale bar
(shown in A for A and B):
20 µm. C, Western blots using anti-Kv1.5 antibody on
highly purified rat microglia, rat heart (positive control), and
nontransfected HEK-293 cells (negative control). D,
E, Kv1.3. Confocal images of representative microglia
from the same 2 DIC (D) and
8 DIC (E) cultures as in
A and B, with the membranes stained
green (OX-42). The red-stained regions
represent anti-Kv1.3 polyclonal antibody with a Cy3-conjugated
secondary antibody. Yellow regions of colocalization are
more extensive in E than in D. Scale bar
(shown in D for D and E):
10 µm. F, Western blots using anti-Kv1.3 antibody on
highly purified rat microglia and nontransfected HEK-293 cells
(negative control).
|
|
Microglia were identified with OX-42 antibody (green fluorescence),
which outlines their membranes by binding to complement receptors on
the microglia surface. A red fluorescent secondary antibody was used
with the K+ channel antibodies; thus
colocalization of the membrane and channel was seen as yellow
fluorescence. We first determined the percentage of OX-42-positive
cells that stained for each channel type at different times in culture
by counting multiple fields of cells from several tissue prints. In
these hippocampal tissue prints, oligodendrocytes and astrocytes, which
express a number of Kv channels, did not stain with anti-Kv1.3
antibody. Only microglia (OX-42-positive cells) stained with anti-Kv1.3
antibody. Anti-Kv1.5 only stained microglia and a small number of
astrocytes, which is not surprising because Kv1.5 can be expressed in
cultured astrocytes (Roy et al., 1996 ). Further controls for antibody
specificity are explained in Materials and Methods.
From 0-5 DIC, 95% of the OX-42-positive cells (127 of 134 cells)
stained distinctly with anti-Kv1.5 antibody. This percentage decreased
slightly by 6-10 DIC (88%, 148 of 168). However, at >10 DIC,
significantly fewer OX-42-positive cells were labeled with anti-Kv1.5
antibody: 49%, 60 of 123 (p < 0.01, 2 test). Using confocal microscopy at
selected times, we noted changes in subcellular localization of the
protein. In Kv1.5-expressing microglia from early cultured tissue
prints, considerable Kv1.5 protein appeared to be on the cell membrane
(Fig. 8A, yellow regions), and a similar
pattern was seen in the >12 microglia examined. After 6-10 DIC, those
cells in which Kv1.5 staining was detectable showed protein almost
exclusively in the cell interior (Fig. 8B), and a
similar pattern was seen in the 10 other microglia examined.
A similar analysis of Kv1.3 antibody staining showed the opposite
trends. From 0-5 DIC, only 15% (21 of 143) of the OX-42-positive cells stained distinctly with anti-Kv1.3 antibody. This proportion increased significantly with time in culture, to 65% (80 of 123) by
6-10 DIC (p < 0.001, 2 test) and to 72% (120 of 166) after
>10 DIC (p < 0.001). After 6-10 DIC, there
was considerable Kv1.3 protein colocalized with OX-42 on the cell
membrane (Fig. 8E, yellow), and a similar
pattern was seen in >10 microglia examined. Thus, both the number of
microglia expressing Kv1.3 and its surface expression increased
dramatically with time. For those few Kv1.3-expressing microglia in
early cultured tissue prints (15%), the staining was mainly in the
cell interior, with a small amount at the membrane (Fig.
8D) (similar pattern in >10 microglia
examined). Despite some apparent expression on the membrane, we never
detected Kv1.3-like current, which raises the possibility that these
Kv1.3 channels are nonfunctional. Tyrosine phosphorylation is one known
mechanism for "silencing" Kv1.3 channels (Fadool et al., 1997 ), and
we have evidence that src-family tyrosine kinases inhibit
the Kv1.3-like current in cultured rat microglia (F. S. Cayabyab, R. Khanna, O. T. Jones, L. C. Schlichter, unpublished observations).
For comparison, we used subunit-specific RT-PCR analysis of whole-cell
lysates from cultured rat microglia (Fig.
9) to determine whether mRNA for other Kv
channels is expressed. Very high levels of Kv1.3 and 1.5 mRNA were seen
in cultured microglia, which is consistent with the high protein
expression for these channels in tissue-printed microglia. There were
also very low levels of mRNA for Kv1.2 and Kv1.6, whereas Kv1.1 and
Kv1.4 were not detected in the same samples. We did not test for
protein expression for any of these channels.

View larger version (64K):
[in this window]
[in a new window]
|
Figure 9.
RT-PCR. For each Kv channel, cDNA was amplified
from cultured rat microglia. For Kv1.1, Kv1.2, Kv1.4, and Kv1.6,
duplicate lanes are shown, whereas three replicates are shown for Kv1.3
and Kv1.5. All bands that appeared were of the correct size, and their
identities were confirmed with restriction enzyme analysis or by
sequencing. Kv1.3 was very highly expressed, Kv1.5 was highly
expressed, and Kv1.2 and Kv1.6 were expressed at low levels.
|
|
Kv current expression and microglia proliferation
Because Kv1.3-like currents were present in proliferating
rat microglia in highly purified cultures (Schlichter et al., 1996 ), we
asked whether the expression of the two apparently different Kv
currents in tissue-printed microglia was correlated with their proliferative state. Microglia cells from different DIC were
patch-clamped, their Kv currents and cumulative inactivation were
recorded, then immunocytochemistry was used to determine whether the
cell recorded from was proliferating (i.e., had incorporated BrdU into
its DNA). From 0-5 DIC, 14 of 15 microglia that had Kv1.5-like
currents lacking cumulative inactivation (Fig. 10A)
were negative for anti-BrdU antibody staining (Fig.
10D) (p < 0.001, 2 test). Before accepting lack of BrdU
staining as a true negative, we ensured that some BrdU-positive cells
were present in every dish. At >6 DIC, all microglia displayed a
Kv1.3-like current with cumulative inactivation (8 of 8 cells) (Fig.
10B), and all showed
strong nuclear staining with anti-BrdU antibody (Fig.
10H) (p < 0.001, 2 test). In all cases, negative
controls were performed on sister cultures by omitting the anti-BrdU
monoclonal antibody. As tissue prints were cultured, the percentage of
microglia that were proliferating increased dramatically (Fig.
11), from ~3% at 0 DIC to 72% at 5 DIC and 93% at 10 DIC. Previous studies have shown low proliferation in vivo (i.e., in resting microglia), whereas in dissociated
cultures increasing proliferation is thought to reflect progressive
microglial activation (Gehrmann et al., 1995 ; Streit and
Kincaid-Colton, 1995 ; Slepko and Levi, 1996 ). Our 0 DIC results suggest
that low proliferation reflects a more resting state, possibly
attributable to the tissue print method, which is less disruptive than
enzymatic/mechanical dissociation. Furthermore, with this method we
studied microglia much sooner after removal from the brain.

View larger version (58K):
[in this window]
[in a new window]
|
Figure 10.
The predominant type of Kv current
correlates with the microglia proliferative state. Tissue prints were
incubated in BrdU, then one microglia from each dish was penetrated
with a patch pipette containing Lucifer yellow to mark the cell for
later immunocytochemical analysis. After the properties of the Kv
currents were recorded, the cells were fixed, permeabilized, and
stained with anti-BrdU antibody. Fixed cells retained sufficient
fluorescent Lucifer yellow to identify the cell from which the
recording was made. A-D, Microglia with
rapidly activating, very slowly inactivating Kv currents that lacked
cumulative inactivation were not proliferative. Current traces from a
microglia in an early cultured tissue print (A).
Four consecutive voltage-clamp steps (numbered) were applied to +30 mV
from a holding potential of 100 mV with an interpulse interval of 10 sec. The same cell is shown under bright-field
(B) and fluorescence, showing Lucifer yellow
(FITC filter set) throughout the cytoplasm (C),
and lack of staining with anti-BrdU antibody (D).
E-H, Microglia with inactivating Kv
currents that showed cumulative inactivation were proliferating. Four
consecutive current traces (E) are shown using
the same protocol as in A, from a microglia in tissue print
cultured for an intermediate time. The same cell is shown under
bright-field (F) and fluorescence optics showing
Lucifer yellow throughout the cytoplasm (G) and
nuclear staining with anti-BrdU antibody
(H).
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Figure 11.
Proliferation of microglia increases in cultured
tissue prints and acquires sensitivity to K+-channel
blockers. Proliferation was determined using the same anti-BrdU
immunocytochemical assay as in Figure 9. Each
K+-channel blocker (4-AP, 5 mM; ChTx, 50 nM;
AgTx-2, 5 nM) was added to a separate dish
containing freshly prepared tissue prints (time 0), then the culture
medium containing the drug (or the control medium) was replaced every
2 d. The percentage of proliferating microglia in each tissue
print was scored as the proportion of IB4-labeled microglia
(out of 100 cells counted for each tissue print), the nuclei of which
incorporated BrdU substrate (labeled with anti-BrdU). Values are
mean ± SD for three separate experiments.
|
|
To determine whether Kv1.3 channels are involved in this proliferation,
we used AgTx-2 and ChTx at >20 times their
Kd values for blocking Kv1.3. At these
concentrations the toxins do not block Kv1.5 channels. However, 4-AP
should block both Kv1.3 and Kv1.5, and although the published
Kd values vary (Table 3), 5 mM is 10 Kd
for both channels. Adding 5 nM AgTx-2 at 0 DIC
had no effect when proliferation was measured at 5 DIC, but
significantly reduced it when measured at 10 DIC (by 60% compared with
the control value at 10 DIC). The lack of a role for Kv1.3 at early
times is not surprising, given the low incidence of Kv1.3 membrane
protein expression and current for the first few days in culture. In
contrast with AgTx-2, 4-AP profoundly reduced the proliferation
measured at 5 DIC, and this difference in blocker sensitivity strongly implicates Kv1.5 in controlling proliferation at early times. From the
increase in effectiveness of AgTx-2, Kv1.3 assumes a greater role in
proliferation by 10 DIC compared with earlier times, consistent with
its increasing prevalence and membrane expression. Because 4-AP is a
more potent inhibitor of proliferation than AgTx-2 at 10 DIC, it
appears that both Kv1.3 and Kv1.5 channels are important at this time.
ChTx (50 nM), which blocks Kv1.3-like current in
microglia (Schlichter et al., 1996 ; Eder, 1998 ), was much more
effective than AgTx-2 at both 5 and 10 DIC, suggesting that it does
more than block Kv1.3 channels. Interestingly, ChTx is known to block
some Ca2+-dependent
K+ currents in immune cells (Lewis and
Cahalan, 1995 ; Eder, 1998 ; Khanna et al., 1999 ).
 |
DISCUSSION |
Changes in expression of Kv channels as tissue prints
are cultured
Previously, the Kv current in cultured microglia was thought to be
Kv1.3, based on similar current properties and the presence of Kv1.3
mRNA (Norenberg et al., 1994 ; Schlichter et al., 1996 ; Eder, 1998 ).
Surprisingly, the Kv current in tissue-printed hippocampal microglia
from 0-5 DIC differed in important ways from Kv1.3. There was very
slow inactivation and lack of cumulative (use-dependent) inactivation,
the voltage dependencies of activation and steady-state inactivation
were shifted to depolarized potentials, 4-AP blocked moderately well
but the sensitivities to TEA, ChTx, and MgTx were much lower than for
Kv1.3 or the Kv previously described in cultured microglia. Most
importantly, AgTx-2, which potently inhibits Kv1.3, did not block the
current. Voltage dependence is not a well conserved property; for
instance, we have found post-insertional changes in the voltage
dependence of Kv1.3 (Pahapill and Schlichter, 1990 ; Chung and
Schlichter 1997 ).
Differences in toxin sensitivity and cumulative inactivation appear to
be diagnostic because cloned and native Kv1.3 channels show the same
pharmacology and cumulative inactivation (Grissmer et al., 1994 ). Our
results strongly argue that the current is not Kv1.3 but instead
resembles Kv1.5 (Table 3). Unfortunately, there is no high-affinity
selective Kv1.5 blocker, and 4-AP is not diagnostic because it blocks
almost all Kv channels at similar concentrations. From the
pharmacological and biophysical properties (Grissmer et al., 1994 ;
Chandy and Gutman, 1995 ; Garcia et al., 1997 ; Mathie et al., 1998 ),
several Kv channels are unlikely candidates for the early current.
Kv1.1, 1.3, and 1.6 are very sensitive to AgTx-2, and Kv1.2 is
sensitive to charybdotoxin and margatoxin, but even 10-50
nM of these toxins did not significantly reduce the
current. TEA (5 mM) should have blocked Kv1.1, 1.6, 2.1, 2.2, and 3.1-3.4, but the effect was nonsignificant. Lack of rapid (N-type) inactivation appears to rule out Kv1.4, 4.1-4.3. These biophysical and pharmacological properties are entirely consistent with
the immunocytochemical evidence that most of these microglia express
abundant Kv1.5 protein on the membrane.
As the tissue prints were cultured, the percentage of microglia
expressing detectable Kv current decreased. Changes in the current's
biophysical and pharmacological properties included increases in
inactivation rate and degree of cumulative inactivation, an increased
sensitivity to AgTx-2, and hyperpolarizing shifts in the activation and
steady-state inactivation curves. After >10 DIC, the Kv current in
tissue-printed microglia was very similar to Kv1.3 (Table 3). In
addition, the number of microglia expressing Kv1.3 immunoreactivity and
localization to the membrane increased with time in culture. Thus,
Kv1.3 is upregulated in microglia as tissue prints are cultured, and
this channel is implicated as a major component of the Kv current.
Although it is not possible to rule out involvement of Kv1.2 or 1.6, their mRNA levels are low in cultured microglia. In tissue-printed
microglia, Kv1.5 and Kv1.3 proteins are abundantly expressed, and their
properties can account for the types and changes in the currents
observed. Therefore, the simplest interpretation of our data is that
there is a switch in Kv1.5 and Kv1.3 expression.
Like other Kv channels within the same family (Isacoff et al., 1990 ;
Ruppersberg et al., 1990 ), Kv1.5 and Kv1.3 could form heteromultimers
in microglia. However, given the incidence and localization of
channels, this is unlikely to occur in our system at both early and
late times. From 0-5 DIC, only ~15% of microglia expressed
detectable Kv1.3 immunoreactivity, and where examined with confocal
microscopy (e.g., Fig. 8), it was largely intracellular, whereas Kv1.5
was present in 95% of microglia and was highly expressed on the
surface of those cells examined. Conversely, at >10 DIC, 49% of cells
had detectable Kv1.5 but it was mainly intracellular, whereas Kv1.3 was
highly expressed on the surface of 72% of the cells. Because at
intermediate times 88% of cells expressed Kv1.5 and 65% expressed
Kv1.3 if expression is on the membrane an intriguing possibility is
that the proportion of heteromeric channels increases with time in
culture, conferring increasing cumulative inactivation and sensitivity
to block by AgTx-2.
Biological implications of changes in Kv expression
Most studies of microglia have used dissociated cultures, and Kv
current expression has been highly variable (Eder, 1998 ): from no
detectable current (Kettenmann et al., 1990 , 1993 ; Brockhaus et al.,
1993 ) to substantial current (Korotzer and Cotman, 1992 ; Norenberg et
al., 1994 ; Schlichter et al., 1996 ). The hypothesis that Kv current is
absent from resting cells (Kettenmann et al., 1990 ; Brockhaus et al.,
1993 ) and upregulated by microglial activation (Norenberg et al., 1994 ;
Fischer et al., 1995 ; Visentin et al., 1995 ; Gebicke-Haerter et al.,
1996 ) has been challenged because ramified microglia, widely believed
to represent resting cells, express a prominent Kv current when exposed
to astrocytes or astrocyte-conditioned medium (Schmidtmayer et al.,
1994 ; Eder et al., 1997 ). One group reported stronger Kv1.5 and weaker
Kv1.3 immunostaining after rat microglia were activated with
lipopolysaccharide (Pyo et al., 1997 ), but membrane channel
localization and a corresponding Kv1.5-like current were not shown.
Because Kv1.3-like current in cultured microglia is apparently affected
by pro-inflammatory stimuli, cytokines, growth factors, and culturing
conditions, multiple factors may control its expression and ability to
contribute to cell function.
Microglia proliferation increased with time in the present study, as
reported for dissociated cultures (Slepko and Levi, 1996 ). We now
provide the first evidence that Kv channels play important roles in
this proliferation and that the specific contributions of each Kv
channel change, consistent with changes in their protein and current
levels. That is, when the Kv1.3 blocker was added from 0-5 DIC, the
period during which proliferation of control cells was dramatically
increased, it had little effect, whereas the nonselective Kv blocker
4-AP profoundly reduced proliferation. Later (e.g., 10 DIC), Kv1.3 also
contributed greatly to proliferation, as seen from the potent
inhibition by AgTx-2. It is interesting that Kv1.5 protein turnover can
be very rapid (~4 hr) (Takimoto et al., 1993 ), and decreases in Kv1.5
mRNA and/or protein can occur in astrocytes and oligodendrocyte
progenitor cells after several days in culture (Attali et al., 1997 ).
The subcellular localization of the channel protein was not examined in
those studies, and unlike microglia, Kv1.5 may not be required because Kv1.5 antisense oligonucleotide treatment did not inhibit
oligodendrocyte proliferation (Attali et al., 1997 ).
It is unlikely that the change we observed in Kv current reflects a
normal in vivo switch during early postnatal development, because it was not a function of the age of the young rats. That is,
95% of microglia had Kv1.5-like currents soon after the tissue prints
were prepared, regardless of the animal's age (from 5 to 14 d
old), nor did the change require a transition from resting (ramified)
to activated (round/reactive) because it occurred in microglia with a
unipolar/bipolar morphology. Instead, there was a strong correlation
with the microglia proliferative state in vitro; the current
was Kv1.5-like in nonproliferating and Kv1.3-like in proliferating
cells. Colony-stimulating factor (CSF-1) (produced by astrocytes)
stimulates microglia proliferation (Gehrmann et al., 1995 ), thus our
previous finding is intriguing; i.e., Kv1.3-like current was present in
dissociated cultured microglia for ~2 weeks but disappeared after
prolonged CSF-1 treatment (Schlichter et al., 1996 ). This may explain
why Kv currents were expressed in only ~22% of mouse microglia
cultured for several weeks with CSF-1 (Fischer et al., 1995 ). The
present study used microglia from rat hippocampus, as opposed to the
usual cultures of enzymatically dissociated neopallium, which should
have selected against hippocampal-derived microglia. In the future, it
will be interesting to determine whether microglia from different brain
regions express different types or amounts of Kv channels, perhaps as a
result of local cellular influences. The tissue print technique we
developed will greatly facilitate such studies.
Biophysical implications of a switch from Kv1.5 to Kv1.3 current
include their different voltage dependencies, which will affect the
membrane potentials over which the channels are active. The resulting
window currents, which are particularly important for nonexcitable
cells (Pahapill and Schlichter, 1990 ; Chung and Schlichter, 1997 ), will
affect their ability to oppose both brief and long depolarizing
influences, such as those resulting from activation of
Cl channels, ATP receptors, or
Ca2+ channels (Kettenmann et al., 1993 ;
Gebicke-Haerter et al., 1996 ; Schlichter et al., 1996 ). Lack of
cumulative inactivation in Kv1.5 should result in increased channel
availability after single or repetitive depolarizations. Furthermore,
Kv1.5 and Kv1.3 channels might be subject to different forms of
regulation, which could allow microglia to respond differently to
receptor-linked stimuli depending on which channel is expressed. There
are also therapeutic implications. If Kv1.5 is most important for
"resting" cells and Kv1.3 is necessary for activated microglia
functions, it may be possible to downregulate overactive microglia
(e.g., after a stroke or acute brain injury) without compromising the
functions of resting microglia (pinocytosis, growth factor, and
cytokine production).
 |
FOOTNOTES |
Received April 22, 1999; revised Sept. 17, 1999; accepted Sept. 27, 1999.
This study was supported by grants to L.C.S. from the Medical Research
Council (MT-13657) and the Heart and Stroke Foundation of Canada
(NA-3182, T3726). We are particularly indebted to R. Khanna for RT-PCR
and Western blot analysis. We thank J. Trogadis for confocal imaging,
X.-P. Zhu and L. Chen for assistance with immunofluorescence, and
M. C. Chang for help with analysis and presentation. Dr. E. F. Stanley provided insightful comments on this manuscript.
Correspondence should be addressed to Dr. L. C. Schlichter, MC
11-417, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. E-mail:
schlicht{at}playfair.utoronto.ca.
 |
REFERENCES |
-
Attali B,
Wang N,
Kolot A,
Sobko A,
Cherepanov V,
Soliven B
(1997)
Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells.
J Neurosci
17:8234-8245[Abstract/Free Full Text].
-
Bertoli A,
Moran O,
Conti F
(1994)
Activation and deactivation properties of rat brain K+ channels of the Shaker-related subfamily.
Eur Biophys J
23:379-384[Web of Science][Medline].
-
Brockhaus J,
Ilschner S,
Banati RB,
Kettenmann H
(1993)
Membrane properties of amoeboid microglial cells in the corpus callosum slice from early postnatal mice.
J Neurosci
13:4412-4421[Abstract].
-
Cai YC,
Douglass J
(1993)
In vivo and in vitro phosphorylation of the T lymphocyte type n (Kv1.3) potassium channel.
J Biol Chem
268:23720-23727[Abstract/Free Full Text].
-
Chamak B,
Mallat M
(1991)
Fibronectin and laminin regulate the in vitro differentiation of microglial cells.
Neuroscience
45:513-527[Web of Science][Medline].
-
Chandy KG,
Gutman GA
(1995)
Voltage-gated potassium channel genes.
In: Handbook of receptors and channels: ligand and voltage-gated ion channels (North RA,
ed), pp 1-71. Boca Raton, FL: CRC.
-
Chung I,
Schlichter LC
(1997)
Native Kv1.3 channels are upregulated by protein kinase C.
J Membr Biol
156:73-85[Web of Science][Medline].
-
Damoiseaux JG,
Dopp EA,
Calame W,
Chao D,
MacPherson GG,
Dijkstra CD
(1994)
Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1.
Immunology
83:140-147[Web of Science][Medline].
-
Dijkstra CD,
Dopp EA,
Joling P,
Kraal G
(1985)
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.
Immunology
54:589-599[Web of Science][Medline].
-
Dubois JM,
Rouzair-Dubois B
(1993)
Role of potassium channels in mitogenesis.
Prog Biophys Mol Biol
59:1-21[Web of Science][Medline].
-
Eder C
(1998)
Ion channels in microglia (brain macrophages).
Am J Physiol
275:C327-C342[Abstract/Free Full Text].
-
Eder C,
Klee R,
Heinemann U
(1997)
Distinct soluble astrocytic factors induce expression of outward K+ currents and ramification of brain macrophages.
Neurosci Lett
226:147-150[Web of Science][Medline].
-
Fadool DA,
Holmes TC,
Berman K,
Dagan D,
Levitan IB
(1997)
Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel.
J Neurophysiol
78:1563-1573[Abstract/Free Full Text].
-
Fischer HG,
Eder C,
Hadding U,
Heinemann U
(1995)
Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states.
Neuroscience
64:183-191[Web of Science][Medline].
-
Garcia ML,
Hanner M,
Knaus H-G,
Koch R,
Schmalhofer W,
Slaughter RS,
Kaczorowski GJ
(1997)
Pharmacology of potassium channels.
Adv Pharmacol
39:425-471.
-
Gebicke-Haerter PJ,
Van Calker D,
Norenberg W,
Illes P
(1996)
Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases.
Neurochem Int
29:1-12[Web of Science][Medline].
-
Gehrmann J,
Matsumoto Y,
Kreutzberg GW
(1995)
Microglia: intrinsic immunoeffector cell of the brain.
Brain Res Rev
20:269-287[Medline].
-
Graeber MB
(1993)
Microglia, macrophages, and the blood-brain barrier.
Clin Neuropathol
12:296-297[Web of Science][Medline].
-
Grissmer S,
Nguyen AN,
Aiyar J,
Hanson DC,
Mather RJ,
Gutman GA,
Karmilowicz MJ,
Auperin DD,
Chandy KG
(1994)
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines.
Mol Pharmacol
45:1227-1234[Abstract].
-
Hailer NP,
Jarhult JD,
Nitsch R
(1996)
Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures.
Glia
18:319-331[Web of Science][Medline].
-
Ichinose M,
Asai M,
Sawada M
(1998)
Activation of outward current by pituitary adenylate cyclase activating polypeptide in mouse microglial cells.
J Neurosci Res
51:382-390[Web of Science][Medline].
-
Isacoff EY,
Jan YN,
Jan LY
(1990)
Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes.
Nature
345:530-534[Medline].
-
Jou I,
Pyo H,
Chung S,
Jung SY,
Gwag BJ,
Joe EH
(1998)
Expression of Kv1.5 K+ channels in activated microglia in vivo.
Glia
24:408-414[Web of Science][Medline].
-
Kettenmann H,
Hoppe D,
Gottmann K,
Banati R,
Kreutzberg G
(1990)
Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages.
J Neurosci Res
26:278-287[Web of Science][Medline].
-
Kettenmann H,
Banati R,
Walz W
(1993)
Electrophysiological behavior of microglia.
Glia
7:93-101[Web of Science][Medline].
-
Khanna R,
Chang MC,
Joiner WJ,
Kaczmarek LK,
Schlichter LC
(1999)
hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes: roles in proliferation and volume regulation.
J Biol Chem
274:14838-14849[Abstract/Free Full Text].
-
Korotzer AR,
Cotman CW
(1992)
Voltage-gated currents expressed by rat microglia in culture.
Glia
6:81-88[Web of Science][Medline].
-
Kotecha SA,
Schlichter LC
(1998)
Early expression of a novel K+ current in rat microglia.
Soc Neurosci Abstr
24:830.
-
Kotecha SA,
Eley DW,
Turner RW
(1997)
Tissue printed cells from teleost electrosensory and cerebellar structures.
J Comp Neurol
386:277-292[Web of Science][Medline].
-
Kreutzberg GW
(1996)
Microglia: a sensor for pathological events in the CNS.
Trends Neurosci
19:312-318[Web of Science][Medline].
-
Lawson LJ,
Perry VH,
Dri P,
Gordon S
(1990)
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.
Neuroscience
39:151-170[Web of Science][Medline].
-
Lewis RS,
Cahalan MD
(1995)
Potassium and calcium channels in lymphocytes.
Annu Rev Immunol
13:623-653[Web of Science][Medline].
-
Mathie A,
Wooltorton JR,
Watkins CS
(1998)
Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents.
Gen Pharmacol
30:13-24[Web of Science][Medline].
-
Milligan CE,
Cunningham TJ,
Levitt P
(1991)
Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain.
J Comp Neurol
314:125-135[Web of Science][Medline].
-
Norenberg W,
Gebicke-Haerter PJ,
Illes P
(1994)
Voltage-dependent potassium channels in activated rat microglia.
J Physiol (Lond)
475:15-32[Abstract/Free Full Text].
-
Ogura KI,
Ogawa M,
Yoshida M
(1994)
Effects of aging on microglia in the normal rat brain: immunohistochemical observations.
NeuroReport
5:1224-1226[Web of Science][Medline].
-
Pahapill PA,
Schlichter LC
(1990)
Modulation of potassium channels in human T lymphocytes: effects of temperature.
J Physiol (Lond)
422:103-126[Abstract/Free Full Text].
-
Perry VH,
Gordon S
(1997)
Microglia and macrophages.
In: Immunology of the nervous system (Keane RW,
Hickey WF,
eds), p 824. New York: Oxford UP.
-
Philipson LH,
Malyev A,
Kuzetsov A,
Chang C,
Nelson DJ
(1993)
Functional and biochemical characterization of the human potassium channel Kv1.5 with a transplanted carboxy-terminal epitope in stable mammalian cell lines.
Biochem Biophys Acta
1153:111-121[Medline].
-
Pyo H,
Chung S,
Jou I,
Gwag B,
Joe EH
(1997)
Expression and function of outward K+ channels induced by lipopolysaccharide in microglia.
Mol Cells
7:610-614[Web of Science][Medline].
-
Roy ML,
Saal D,
Perney T,
Sontheimer H,
Waxman SG,
Kaczmarek LK
(1996)
Manipulation of the delayed rectifier Kv1.5 potassium channel in glial cells by antisense oligodeoxynucleotides.
Glia
18:177-184[Web of Science][Medline].
-
Ruppersberg JP,
Schroter KH,
Sakmann B,
Stocker M,
Sewing S,
Pongs O
(1990)
Heteromultimeric channels formed by rat brain potassium-channel proteins.
Nature
345:535-537[Medline].
-
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
In: Molecular cloning: a laboratory manual, Ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
-
Schlichter LC,
Sakellaropoulos G,
Ballyk B,
Pennefather PS,
Phipps DJ
(1996)
Properties of K+ and Cl
channels and their involvement in proliferation of rat microglial cells.
Glia
17:225-236[Web of Science][Medline]. -
Schmidtmayer J,
Jacobsen C,
Miksch G,
Sievers J,
Parwaresch R
(1994)
Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: membrane currents.
Glia
12:259-267[Web of Science][Medline].
-
Slepko N,
Levi G
(1996)
Progressive activation of adult microglial cells in vitro.
Glia
16:241-246[Web of Science][Medline].
-
Sobko A,
Peretz A,
Shirihai O,
Etkin S,
Cherepanova V,
Dagan D,
Attali B
(1998)
Heteromultimeric delayed-rectifier K+ channels in Schwann cells: developmental expression and role in proliferation.
J Neurosci
18:10398-10408[Abstract/Free Full Text].
-
Spencer RH,
Sokolov Y,
Li H,
Takenaka B,
Milici AJ,
Aiyar J,
Nguyen A,
Park H,
Jap BK,
Hall JE,
Gutman GA,
Chandy KG
(1997)
Purification, visualization, and biophysical characterization of Kv1.3 tetramers.
J Biol Chem
272:2389-2395[Abstract/Free Full Text].
-
Streit WJ,
Kincaid-Colton CA
(1995)
The brain's immune system.
Sci Am
273:54-61[Web of Science][Medline].
-
Streit WJ,
Graeber MB,
Kreutzberg GW
(1988)
Functional plasticity of microglia: a review.
Glia
1:301-307[Web of Science][Medline].
-
Takimoto K,
Fomina AF,
Gealy R,
Levitan ES
(1993)
Dexamethasone rapidly induces Kv1.5 K+ channel gene transcription and expression in cloned pituitary cells.
Neuron
11:359-369[Web of Science][Medline].
-
Uebele VN,
England SK,
Gallagher DJ,
Snyders DJ,
Bennett PB,
Tamkun MM
(1998)
Distinct domains of the voltage-gated K+ channel Kv
1.3 -subunit affect voltage-dependent gating.
Am J Physiol
274:C1485-C1495[Abstract/Free Full Text]. -
Visentin S,
Agresti C,
Patrizio M,
Levi G
(1995)
Ion channels in rat microglia and their different sensitivity to lipopolysaccharide and interferon-
.
J Neurosci Res
42:439-451[Web of Science][Medline]. -
Wu CH,
Wen CY,
Shieh JY,
Ling EA
(1993)
A quantitative study of the differentiation of microglial cells in the developing cerebral cortex in rats.
J Anat
182:403-413.
-
Wu YP,
Ling EA
(1998)
Induction of microglial and astrocytic response in the adult rat lumbar spinal cord following middle cerebral artery occlusion.
Exp Brain Res
118:235-242[Web of Science][Medline].
-
Zhou J,
Jeron A,
London B,
Han X,
Koren G
(1998a)
Characterization of a slowly inactivating outward current in adult mouse ventricular myocytes.
Circ Res
83:806-814[Abstract/Free Full Text].
-
Zhou W,
Cayabyab FS,
Pennefather PS,
Schlichter LC,
DeCoursey TE
(1998b)
HERG-like K+ channels in microglia.
J Gen Physiol
111:781-794[Abstract/Free Full Text].
Copyright © 1999 Society for Neuroscience 0270-6474/99/192410680-14$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Gagnon, J.-H. Kim, J. O. Schorge, B. Ye, B. Liu, K. Hasselblatt, W. R. Welch, C. A. Bandera, and S. C. Mok
Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients
Clin. Cancer Res.,
February 1, 2008;
14(3):
764 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Beck, R. Penner, and A. Fleig
Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (ICRAC) but not Ca2+-activated TRPM4-like currents (ICAN) in cultured mouse microglial cells
J. Physiol.,
January 15, 2008;
586(2):
427 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vicente, A. Escalada, N. Villalonga, L. Texido, M. Roura-Ferrer, M. Martin-Satue, C. Lopez-Iglesias, C. Soler, C. Solsona, M. M. Tamkun, et al.
Association of Kv1.5 and Kv1.3 Contributes to the Major Voltage-dependent K+ Channel in Macrophages
J. Biol. Chem.,
December 8, 2006;
281(49):
37675 - 37685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Miguel-Velado, A. Moreno-Dominguez, O. Colinas, P. Cidad, M. Heras, M. T. Perez-Garcia, and J. R. Lopez-Lopez
Contribution of Kv Channels to Phenotypic Remodeling of Human Uterine Artery Smooth Muscle Cells
Circ. Res.,
December 9, 2005;
97(12):
1280 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Beeton and K. G. Chandy
Potassium Channels, Memory T Cells, and Multiple Sclerosis
Neuroscientist,
December 1, 2005;
11(6):
550 - 562.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W Newell and L. C Schlichter
Integration of K+ and Cl- currents regulate steady-state and dynamic membrane potentials in cultured rat microglia
J. Physiol.,
September 15, 2005;
567(3):
869 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Fordyce, R. Jagasia, X. Zhu, and L. C. Schlichter
Microglia Kv1.3 Channels Contribute to Their Ability to Kill Neurons
J. Neurosci.,
August 3, 2005;
25(31):
7139 - 7149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rus, C. A. Pardo, L. Hu, E. Darrah, C. Cudrici, T. Niculescu, F. Niculescu, K. M. Mullen, R. Allie, L. Guo, et al.
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
PNAS,
August 2, 2005;
102(31):
11094 - 11099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vicente, A. Escalada, C. Soler, M. Grande, A. Celada, M. M. Tamkun, C. Solsona, and A. Felipe
Pattern of Kv{beta} Subunit Expression in Macrophages Depends upon Proliferation and the Mode of Activation
J. Immunol.,
April 15, 2005;
174(8):
4736 - 4744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Chittajallu, A Aguirre, and V Gallo
NG2-positive cells in the mouse white and grey matter display distinct physiological properties
J. Physiol.,
November 15, 2004;
561(1):
109 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vicente, A. Escalada, M. Coma, G. Fuster, E. Sanchez-Tillo, C. Lopez-Iglesias, C. Soler, C. Solsona, A. Celada, and A. Felipe
Differential Voltage-dependent K+ Channel Responses during Proliferation and Activation in Macrophages
J. Biol. Chem.,
November 21, 2003;
278(47):
46307 - 46320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiang, E. W. Newell, and L. C. Schlichter
Regulation of a TRPM7-like Current in Rat Brain Microglia
J. Biol. Chem.,
October 31, 2003;
278(44):
42867 - 42876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Koni, R. Khanna, M. C. Chang, M. D. Tang, L. K. Kaczmarek, L. C. Schlichter, and R. A. Flavell
Compensatory Anion Currents in Kv1.3 Channel-deficient Thymocytes
J. Biol. Chem.,
October 10, 2003;
278(41):
39443 - 39451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Wang, D. D. Krueger, and A. Bordey
Biophysical Properties and Ionic Signature of Neuronal Progenitors of the Postnatal Subventricular Zone In Situ
J Neurophysiol,
October 1, 2003;
90(4):
2291 - 2302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Mackenzie, H. Chirakkal, and R. A. North
Kv1.3 potassium channels in human alveolar macrophages
Am J Physiol Lung Cell Mol Physiol,
October 1, 2003;
285(4):
L862 - L868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.D. Gong, J.C.H. Li, G.P.H. Leung, K.H. Cheung, and P.Y.D. Wong
A BKCa to Kv Switch During Spermatogenesis in the Rat Seminiferous Tubules
Biol Reprod,
July 1, 2002;
67(1):
46 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Manikkam, Y. Li, B. M. Mitchell, D. E. Mason, and L. C. Freeman
Potassium Channel Antagonists Influence Porcine Granulosa Cell Proliferation, Differentiation, and Apoptosis
Biol Reprod,
July 1, 2002;
67(1):
88 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. M. Smith, H.-W. Tsui, E. W. Newell, X. Jiang, X.-P. Zhu, F. W. L. Tsui, and L. C. Schlichter
Functional Up-regulation of HERG K+ Channels in Neoplastic Hematopoietic Cells
J. Biol. Chem.,
May 17, 2002;
277(21):
18528 - 18534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Cayabyab and L. C. Schlichter
Regulation of an ERG K+ Current by Src Tyrosine Kinase
J. Biol. Chem.,
April 12, 2002;
277(16):
13673 - 13681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chittajallu, Y. Chen, H. Wang, X. Yuan, C. A. Ghiani, T. Heckman, C. J. McBain, and V. Gallo
Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle
PNAS,
February 19, 2002;
99(4):
2350 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Mason, K. E. Mitchell, Y. Li, M. R. Finley, and L. C. Freeman
Molecular Basis of Voltage-Dependent Potassium Currents in Porcine Granulosa Cells
Mol. Pharmacol.,
January 1, 2002;
61(1):
201 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cheong, A. M. Dedman, S. Z. Xu, and D. J. Beech
KV{alpha}1 channels in murine arterioles: differential cellular expression and regulation of diameter
Am J Physiol Heart Circ Physiol,
September 1, 2001;
281(3):
H1057 - H1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Cheong, A M Dedman, and D J Beech
Expression and function of native potassium channel (KV{alpha}1) subunits in terminal arterioles of rabbit
J. Physiol.,
August 1, 2001;
534(3):
691 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Khanna, L. Roy, X. Zhu, and L. C. Schlichter
K+ channels and the microglial respiratory burst
Am J Physiol Cell Physiol,
April 1, 2001;
280(4):
C796 - C806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Czarnecki, S. Vaur, L. Dufy-Barbe, B. Dufy, and L. Bresson-Bepoldin
Cell cycle-related changes in transient K+ current density in the GH3 pituitary cell line
Am J Physiol Cell Physiol,
December 1, 2000;
279(6):
C1819 - C1828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Schilling, F. N. Quandt, V. V. Cherny, W. Zhou, U. Heinemann, T. E. Decoursey, and C. Eder
Upregulation of Kv1.3 K+ channels in microglia deactivated by TGF-beta
Am J Physiol Cell Physiol,
October 1, 2000;
279(4):
C1123 - C1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. MacFarlane and H. Sontheimer
Modulation of Kv1.5 Currents by Src Tyrosine Phosphorylation: Potential Role in the Differentiation of Astrocytes
J. Neurosci.,
July 15, 2000;
20(14):
5245 - 5253.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|